Eclipse adopts new name, new location and new vision
This article was originally published in Clinica
Eclipse Surgical Technologies, one of the companies developing laser-based mycocardial revascularisation treatments, is to take a new name - CardioGenesis - to more accurately reflect the company's "new, expanded vision". The company, which has been forced to cut costs, has set profitability as its primary goal. The 12-year-old company has an accumulated loss to date of $156 million.